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Ageing manifests itself in the progressive decline of 
biological functions, reducing the capability of an 
organism to respond to internal and external stress [1]. 
Features of mitochondrial dysfunction such as reduced 
respiratory chain efficiency, morphological alterations 
and mtDNA mutations are entwined with the process of 
ageing and age-related disease [2, 3]. Rapid advances in 
lipidomic techniques have led to recent progress in our 
understanding of the importance of lipids in maintaining 
lifelong health and changes in disease [4,5]. Mass 
spectrometry based lipidomics has revealed the complex 
lipid composition ranging from organelles and cells to 
tissues and whole organisms [6,7]. Whilst the lipid 
composition of the mitochondrion has been investigated 
[8-10] little is known  about  the  changes  to  the  whole  
 
 
mitochondrial lipidome in different tissue types with 
ageing  [11].  
 
Mitochondria are highly specialised organelles with a 
complex structure consisting of two membranes. Lipids 
are distributed differently between the inner mitochon-
drial membrane and outer mitochondrial membrane. 
The outer mitochondrial membrane is fluid and contains 
higher levels of cholesterol and phosphatedylinositol. In 
contrast, the inner mitochondrial membrane is highly 
folded, enriched in phosphatidylethanolamines and 
contains cardiolipin, a component synthesised and 
restricted to this membrane layer [12]. Mitochondria are 
characterised by a high, phospphatidylethanolamine and 
phosphatidylcholine content and low levels of sterols 
and sphingolipids [13].  
 



















and  age  ranges.  Ultra‐high  performance  liquid  chromatography  coupled  with  high  resolution  mass




levels  of  phosphatidylethanolamines  are  known  to  decrease  mitochondrial  membrane  fluidity  and  are
connected with accelerated ageing. In mitochondria from skeletal muscle we propose that increased age causes
a  metabolic  shift  in  the  conversion  of  diacylglycerol  so  that  triglycerides  predominate  compared  with
phosphatidylethanolamines.  This  is  the  first  time mitochondrial  lipid  content  in  normal healthy mammalian
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Harman first proposed the mitochondrial free radical 
theory of ageing 60 years ago [14]. This theory 
postulates that the accumulation of reactive oxygen 
species (ROS) over the lifespan results in oxidative 
damage to mitochondrial DNA, proteins and lipids. 
Lipids are particularly vulnerable to oxidation from 
ROS since the respiratory chain, a producer of ROS, is 
embedded within the inner mitochondrial membrane 
[15]. ROS and free radicals are more soluble in the lipid 
bilayer and interact with polyunsaturated fatty acids to 
form highly reactive lipid radicals such as electrophilic 
aldehydes [16].  
 
Oxidative damage to the mitochondrial lipidome with 
ageing can cause mitochondrial dysfunction [17,1]. 
Cardiolipin interacts with proteins of the inner 
membrane and is vital for processes such as oxidative 
phosphorylation [18–20], mitochondrial dynamics [21] 
and apoptosis [22,23]. Reduced levels of cardiolipin not 
only cause free radical production and lipid 
peroxidation but also result in decreased mitochondrial 
functionality [24]. Mitochondrial morphodynamics are 
regulated by lipid composition with species such as 
diglycerides, phosphatidylethanolamines, phsophatidyl-
serines and cholesterol all being essential to create a 
negative membrane curvature, required for mitochon-
drial fusion [25]. Reductions in the abundance of these 
lipids within the mitochondria are suggested to cause 
the enlarged and fragmented mitochondria that are 
associated with ageing [26].  
 
We set out to evaluate the mitochondrial lipidome 
through the ageing process in two tissue types that are 
known to be undergo functional decline during normal 
ageing, the brain and skeletal muscle, respectively. 
Certain lipids are synthesised by the organelle itself 
giving us direct insight into the mechanics of 
mitochondrial ageing [13]. Lipid content of skeletal 
muscle is postulated to have a role in longevity but it is 
only recent advances in the analyses of these types of 
molecules that allow comprehensive characterisation in 
mitochondrial fractions [27]. We interrogated the brain 
and skeletal muscle mitochondria in young (4-11 
weeks) mice, the equivalent human age of early 
adolescence, and old (78 weeks) mice reflecting middle 
age in humans (approximately 56 years) [28]. We report 





The mitochondrial lipidomes differ distinctly 
between muscle and brain and change with age 
 
We analysed the lipid composition of enriched 
mitochondrial fractions from young (4-11 weeks) and 
older (78 weeks) mouse brain and skeletal muscle 
tissues using UHPLC-HRMS. In total we determined 
that 8,814 lipids alter in abundance in the mitochondria. 
Analyses of our datasets show that there are clear tissue 
specific differences in mitochondrial lipid profiles. 
Brain and muscle mitochondria each have characteristic 
compositions, and the lipid composition of each is 
strongly affected by increased age (Fig. 1). There is 
little overlap between the most changed lipids in the 
muscle and brain mitochondria, demonstrating that each 
tissue ages along independent and characteristic 
pathways. 
 
The top lipid changes to the brain and skeletal 
muscle mitochondria with ageing 
 
With such profound differences between the lipid sets 
of each tissue type we analysed them separately to find 
molecular species with the greatest change in 
abundance per tissue. The top lipids with the highest 
significant difference (Wilcoxon rank test and 
Bonferroni correction) and the greatest fold change 
were selected from each of the brain and skeletal muscle 
mitochondria LC-MS datasets). Visual representations 
of the top 6 lipid changes in brain and skeletal muscle 
mitochondria are shown (Figs. 2 and 3).  
 
Three of the top five lipids to significantly increase in 
abundance in old brain mitochondria were identified as 
phosphatidylethanolamines and showed a fold change 
increase ranging from 3.22 to 4.17. Of the top five 
lipids to decrease with ageing brain, two lipids were 
identified as fatty acids. One of these two lipids, with a 
mass value (m/z 335.295), tentatively identified as 
docosadienoic acid C22:4, has a 3-fold significant 
decrease in abundance in aged brain mitochondria. The 
second lipid (m/z 307.264), tentatively identified as 
eicosadienoic acid C20:2, significantly decreases over 
two-fold in mitochondria of aged brain (Supplementary 
Table 1).  
  
Of the top five lipids that increase in abundance with 
ageing in the skeletal muscle mitochondria two lipids 
were identified as cardiolipins. The lipid m/z 1466.917, 
tentatively identified as cardiolipin (72:10) increases in 
the aged skeletal muscle mitochondria by a fold change 
of 12.37. The lipid m/z 1693.97, tentatively identified as 
cardiolipin (70:6), increases over 9-fold (9.31) in 
abundance in the aged skeletal muscle mitochondria. Of 
the top five lipids to decrease in abundance in the aged 
skeletal muscle mitochondria, three lipids were 
identified as phosphatidylcholine. One of these lipid 
changes is the polyunsaturated fatty acid m/z 331.263, 
tentatively identified as docosatetraenoic acid, which 
decreases in abundance in the aged skeletal muscle by a 
fold change of 10.12 (Supplementary Table 2).  








































Fatty acid composition decreases in brain 
mitochondria from aged animals 
 
46 fatty acids are identified within our dataset using the 
Human Metabolome and Lipid Maps databases. This 
group can be further defined as consisting of poly-
unsaturated fatty acids (PUFAs), Monounsaturated fatty 
acids (MUFAs), saturated fatty acids (SFA) and 
hydroxyl fatty acids (HFA) (refer to Supplementary 
Table 3). We see a decrease in the abundance of most of 
these fatty acids with age in brain mitochondria (Fig. 3): 
94% of them decrease in the old brain mitochondria 
with fold changes in the abundance of the lipids ranging 
from 0.80 to 27.62 (Fig. 4). Omega-3 PUFAs 
(ω3PUFAs) decrease and linolenic, docosapentaenoic 
acid, eicosatrienoic acid and docosahexaenoic acid 








































brain mitochondria. MUFAs, SFAs and HFAs also 
decrease in abundance in the aged brain mitochondria 
and make up the remaining 52% of the fatty acids 
identified (fig 4B).  Representative scatter plots for each 
fatty acid classes; PUFA, MUFA, SFA and HFA are 
shown (Fig. 4C-F).  
 
Triglycerides increase in aged skeletal muscle 
mitochondria 
 
An increase in the abundance of triglycerides (TG) 
appears to be a characteristic feature of the aged skeletal 
muscle mitochondrial lipidome (Fig. 5A). Representative 
scatter plots are shown for two of the triglycerides 
identified with the greatest fold change (Fig. 5C and 5D). 
The lipid m/z 846.753, tentatively identified as TG (50:3) 
increases in abundance in the old skeletal muscle 
Figure 1. Mitochondrial  lipid composition differs between tissue types and changes with age.  (A) Orthogonal partial  least
square‐discriminant analysis (OPLS‐DA) of lipids found in the mitochondria of murine brain and skeletal muscle. Separation across the x‐
axis  is according to tissue type. Along the y‐axis separation delineates age. There are clear  lipid compositional alterations between the
mitochondria  isolated  from  the  two  tissue  types and with differences  in age of  the  tissue.  (B) OPLS‐DA of  lipid composition of murine
brain mitochondria aged 4‐11 weeks  (pink)  (n=10) and 78 weeks  (red)  (n=10).  (C) OPLS‐DA of  the  lipid composition of murine muscle
mitochondria aged 4‐11 weeks (yellow) (n=9) and 78 weeks (blue) (n=10).  
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mitochondria by a fold change of 1.92. The lipid m/z 
874.785, tentatively identified as TG (52:3) increases in 
abundance in the old skeletal muscle mitochondria by a 
fold change of 1.57 (Supplementary Table 4). 
 
Phosphatidylethanolamines decrease in aged skeletal 
muscle mitochondria 
 
There is a reduction in the abundance of phosphatidy-
lethanolamines (PEs) in aged (78 weeks) skeletal 
muscle mitochondria compared to young (4-11 weeks) 
skeletal muscle mitochondria. 73% of the PE species we 
identified decrease in abundance in the aged skeletal 
muscle mitochondria (Fig. 5A). Representative scatter 










































greatest fold change with ageing  (Fig. 5F and 5H).  The  
PEs m/z 717.566 and 822.600 both significantly 
decrease in abundance in the old skeletal muscle 
mitochondria by fold changes of 7.16 and 5.17, 




We demonstrate that the composition of the murine 
mitochondrial lipidome is different between two 
energetically active tissues, muscle and brain. We also 
discovered age-specific changes of mitochondrial lipids 
in both of these tissues. These mitochondrial lipid 
signatures describe changes that can classify the tissue 















































in  abundance  by  a  fold  change  of  4.68  in  the  aged  brain  mitochondria.  (C)  The  lipid  m/z  810.643  tentatively  identified  as
phosphatidylethanolamine (42:2) significantly increases in abundance by a fold change of 4.17 in the aged brain mitochondria. (D)
The lipid m/z 866.594 tentatively identified as a phosphatidylserine (42:4) significantly decreases in abundance by a fold change of
















































The phospholipid class has been previously shown to 
alter with ageing in brain and liver mitochondria [11]. 
In comparison, our study uses a global lipidomic 
approach to investigate lipid species from every class of 
the mitochondrial lipidome during ageing. We uncover 
in detail the vast extent of tissue-specific mitochondrial 
lipid changes with age in mouse.  
 
The mouse brain mitochondrial lipidome undergoes a 
reduction in the abundance of fatty acids with age. With 
ageing there is an increase in ω6PUFAs and a decrease 
in ω3PUFAs in the mitochondrial membrane [29]. 
Changes in the abundance of PUFAs with age alters the 
fluidity and permeability of mitochondrial membranes 










































membrane could serve as a protective mechanism to 
reduce the susceptibility of the mitochondrial membrane 
to oxidative damage.   The normal ageing process is 
accompanied by a decline in ω3PUFAs in whole brain 
tissue and increasing dietary intake of ω3PUFAs has 
been suggested to slow the age-related decline in 
cognition [31].  Indeed, supplementation of ω3PUFAs 
influence mitochondrial function by restoring age 
related reductions in respiration and also improved ATP 
levels in the brains of aged mice [32]. 
 
We find that TG content is increased in the older 
skeletal muscle mitochondria. TGs are crucial for 
normal cellular functioning such as energy storage and 








fold  change  of  7.52  in  aged  skeletal  muscle  mitochondria.  (D)  The  lipid  m/z  564.305  tentatively  identified  as  lyso‐
phosphatidylcholine (20:5/0:0) decreases  in abundance by a fold change of 23.19  in aged skeletal muscle mitochondria. (E) The
lipid m/z 1504.035 tentatively identified as phosphatidylethanolamine (36:3) decreases in abundance by a fold change of 12.96 in
aged  skeletal  muscle  mitochondria.  (F)  The  lipid  m/z  331.263  tentatively  identified  as  docosatetraenoic  acid  decreases  in
abundance by a fold change of 10.12 in aged skeletal muscle mitochondria. Scatter plots display the abundance ± SEM. We used
the Wilcoxon  rank  test  and Bonferroni  correction  (p<0.15).  Lipids were  identified  using  Lipid Maps  and Human Metabolome
databases. Refer to Supplementary Tables 1 and 2  for  the  top 50  lipid changes. Abbreviations: ceramide  (cer), cardiolipin  (CL),
phosphatidylcholine (PC), lysophosphatidylcholine (lysoPC) and phosphatidylethanolamine (PE). 
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increased general accumulation of TGs is found in 
ageing, obesity and type 2 diabetes [33,34]. TG content 
has previously been shown to increase in mitochondria-
rich tissues; heart, liver and skeletal muscle with ageing 
in rats, supporting the findings from our study [35]. 
Accumulation of cytosolic levels of TG have been 
associated with mitochondrial dysfunction due to 
impaired signalling for fat metabolism [36]. 
Furthermore, high triglyceride levels have been 
associated with reduced ATP production and increased 
ROS production when mitochondrial fusion is impaired 
[35].  We provide evidence that mitochondrial TG 
content increases with ageing.  
 
A reduction in the abundance of PE is seen in our 
ageing skeletal muscle mitochondria lipid set. PE is the 
second most abundant phospholipid class in the 
mitochondria and reductions in PEs have a significant 
impact on mitochondrial functionality through the 





































drial lipid composition and changes to the abundance of 
PEs, specifically a decline in PEs, within the 
mitochondrial membrane lead to abnormal 
mitochondrial morphology, reduced respiratory capacity 
and impaired fusion and fission [18,38,39]. The 
abundance of PE is significantly reduced in the 
substantia nigra pars compacta of Parkinson’s disease 
patients compared to controls [40]. Mitochondria from 
yeast lacking Psd1, the key enzyme that synthesizes PE, 
show impaired Mgm1-driven mitochondrial fusion 
along with improper mixing of the lipids in the 
membrane during fusion [39]. Enlarged mitochondria 
are a common feature of ageing and may arise as a 
result of impaired fusion events from reduced PE levels. 
Indeed, manipulating the abundance of the Psd1 protein 
has been associated with changes to ageing. Lifespan 
has been altered in yeast, Drosophila and mammalian 
cells (U2OS and H4) by changing the abundance of PE 
[41]. PE clearly plays an extremely important role in 






































decrease  in the ageing brain mitochondria. 94% of the fatty acids  identified (Supplementary Table 5) decrease with ageing  in the
brain mitochondria. 48% of  the  fatty acids  found  to decrease were  identified as polyunsaturated  fatty acids  (PUFA), 24% were
saturated fatty acids (SFA), 24% monounsaturated fatty acids (MUFA) and a small percentage, 4%, were identified as hydroxy fatty
acids  (HFA).  (C) Representative  scatter plot  for  the  lipid m/z 357.2796,  tentatively  identified  as PUFA C22:5.  This  lipid  shows  a
significant decrease in abundance in 78 week old brain mitochondria (n=10) compared to 4‐11 week old brain mitochondria (n=10),
p=0.048.  (D) Representative scatter ploy  for  the  lipid m/z 393.3732,  tentatively  identified as a C26.1 MUFA shows a decrease  in







































We observe an increase in the abundance of TGs and a 
decrease in the abundance of PEs with ageing in 
skeletal muscle mitochondria. TGs and glycerophospho-
lipids share two common precursors, fatty acyls and 
glycerol-3-phosphate. The acylation of glycerol-3-
phosphate and fatty acyl-CoA yields diacylglycerol-3-
phosphate, more commonly known as phosphatide. The 
biosynthesis of phosphatide can occur in the 
endoplasmic reticulum and the outer mitochondrial 
membrane. Phosphatidate can either be converted to 
TGs or to glycerophospholipids (such as phosphatidy-
lethanolamine). Phosphatidate is dephosphorylated by 
the enzyme phosphatidate phosphatase yielding 
diacylgycerols. Diacyglycerol synthesis is an inter-
mediate step towards the synthesis of TGs catalysed by 
the enzyme diglyceride acyltransferase. Membrane 
phospholipids, phosphatidylcholine and phospha-
tidylethanolamine are also synthesised from diacyl-
glycerols [42]. We propose that the production of TGs 
and PEs from diacylglycerols differs with ageing in the 




































we see that diacylglycerols may be directed towards 
glycerophospholipid synthesis. Whilst in the older 
mitochondria we observe the opposite indicating that 





Our data show that enriched mitochondrial fractions 
have characteristic lipidomic profiles specific to the age 
and type of tissue, echoing our findings in the 
mitochondrial proteome [43]. We find the brain 
mitochondrial lipidome is highly modulated with 
ageing, with fatty acids decreased in older animals. We 
show that skeletal muscle mitochondria have increased 
TG content and decreased PE content with age. During 
the normal lifespan the conversion of diacylglycerols to 
TGs is favoured over the production of PEs. Tissue-
specificity is a factor to be considered carefully in order 
to be able to properly understand mitochondrial biology 
within normal ageing. 
 
Figure 5. The abundance of triglycerides (TGs) increases in the aged skeletal muscle mitochondria whilst the abundance
of phosphatidylethanolamines  (PEs) decreases.    (A)  78% of  TGs  identified  increase  in  abundance with  ageing  in  the  skeletal
muscle  mitochondria.  Whilst  in  the  skeletal  muscle  mitochondria  73%  of  PEs  identified  decrease  in  abundance  with  ageing.  (B)
Proposed pathways for the lipid changes in the young (4‐11 weeks) and old (78 weeks) mitochondria.  In the young mitochondria the
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Brain and skeletal muscle tissue were collected from 
young (4-11 week old) and older (78 weeks) C57BL/6J 
female mice (Charles River). The mitochondrial 
fraction was isolated from the tissues as previously 
described [44].  
 
Mitochondrial lipid extraction 
 
10 biological replicates of each condition (4-11 weeks 
brain, 78 weeks brain, 4-11 weeks skeletal muscle and 
78 weeks skeletal muscle) were taken and enriched 
mitochondrial fractions prepared, these underwent lipid 
extraction. 100 μl of chloroform/methanol (2:1) was 
added to each sample and mixed for 20 min using a 
multiplace vortex before undergoing centrifugation 
(1300 rpm, 10 min) at 4°C. The supernatants were 
removed to HPLC vials. Isopropanol (50 μl) was added 
to each vial.  
 
Lipidomics analysis using accurate mass 
spectrometry 
 
Accurate mass LC-MS was performed on the 
mitochondrial lipid extracts (10 µL injection volume) 
using an Accela LC coupled with an Exactive mass 
spectrometer (ThermoFisher Scientific, Waltham, USA) 
in positive and negative electrospray ionisation modes 
(ESI). An ACE EXL Excel 2µm SuperC18 2.1 x 50mm 
column equipped with an appropriate guard column was 
maintained at 40°C with a variable flow rate throughout 
analysis. The LC gradient program used a water 
60%/Acetonitrile 40% (A)-to-water (10%)/acetonitrile 
(100%)/isopropanol (80%) gradient (B) modified with 
0.1% ammonium acetate (30%-100 %B over 12 
minutes). Ions were monitored within the range of m/z 
100 to 1500 (ESI voltage: 3500, capillary temperature: 
350°C, scan rate: 250 ms, FT resolution: 25,000). A 
pooled quality control sample comprising 5 µL from 
each experimental sample was generated and injected 
throughout the run. LC-MS data were aligned and 
exported using the propriety software Progenesis QI 




A Wilcoxen rank sum test was performed on the data 
using R (https://www.r-project.org/). Lipid analytes 
with one or more replicates two standard deviations 
above or below the mean were removed from the 
dataset before the Bonferroni correction was carried out. 
Multivariate analysis- orthogonal partial least square-
discriminant analysis (OPLS-DA) was carried out 
(SIMCA-P 13.0.2 version, Umetrics AB, Umea, 
Sweden).  Lipids were identified using accurate mass 
determinations by reference to the Lipid Maps and 
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906.632 5.03 M+H + Hydroxylated Sulfatide (42:2) 0.000011 0.024 ↑ 6.74 
826.672 5.02 M+H + PC(40:3) 0.000011 0.024 ↑ 4.68 
810.643 5.52 M-H - PE(42:2) 0.000011 0.024 ↑ 4.17 
1064.721 6.12 M-H - PE(O-44:2) 0.000011 0.024 ↑ 3.86 
856.676 5.8 M+H + PE(44:2) 0.000011 0.024 ↑ 3.22 
866.594 5.7 M+H - PS(42:4) 0.000011 0.024 ↓ -3.83 
732.588 5.89 M+H + PE (o-32:1) 0.000011 0.024 ↓ -3.19 
335.295 2.12 M-H - Docosadienoic acid C22:4 0.000022 0.048 ↓ -3 
690.508 3.7 M-H - PE(32:0) 0.000011 0.024 ↓ -2.25 











Adduct ESI mode Lipid identity 
Wilcoxon 
rank p value 
Wilcoxon rank 
and Bonferroni 






642.568 5.25 M-H - Cer(36:0) 0.000041 0.128 ↑ 12.37 
1466.917 6.56 M+Na-2H - CL(72:10) 0.000041 0.128 ↑ 9.31 
874.537 5.11 M+H + PC(42:11) 0.000041 0.128 ↑ 7.52 
1693.97 7.21 Na-Ac+Na -  CL (70:6) 0.000041 0.128 ↑ 7.46 
876.575 3.45 M+Ac-H - PE(42:7) 0.000041 0.128 ↑ 7.16 
564.305 0.81 M+Na + LysoPC(20:5/0:0) 0.000041 0.128 ↓ -23.19 
1504.035 4.16 2M+Na-2H -  PE(36:3) 0.000041 0.128 ↓ -12.96 
331.263 1.22 M-H - Docosatetraenoic acid 0.000041 0.128 ↓ -10.12 
862.627  5.39 M+Na + PC(40:3) 0.000041 0.128 ↓ -7.75 
924.671 5.52 M+Ac-H - PC(42:4) 0.000041 0.128 ↓ -7.32 
The mitochondrial  lipidome was compared between young 4‐11 weeks (n=9) and old 78 weeks (n=9) skeletal muscle tissue. The top five 
lipids with  the  greatest  significant difference  and highest  fold  change  increase with  ageing were  selected.  The  top  five  lipids with  the 
greatest  significant  difference  and  highest  fold  change  decrease  with  ageing  were  selected.  Lipids  were  identified  using  the  Human 
metabolome database and Lipid maps. Only  lipid  identities with a mass error of  less than 5ppm were selected. Abbreviations: ceramide 
(cer), cardiolipin (CL), phosphatidylcholine (PC), lysophosphatidylcholine (lysoPC) and phosphatidylethanolamine (PE). 































































































391.358 3.34 - C26:2 PUFA ↓ -27.62 
361.311 2.27 - C24:3 PUFA ↓ -9.36 
313.078 3.28 - C20:0 SFA ↓ -6.92 
393.373 4.01 - C26:1 MUFA ↓ -6.75 
363.327 2.65 - C24:2 PUFA ↓ -5.86 
293.248 1.51 - C19:2 PUFA ↓ -5.85 
385.311 2.05 - C26:5 PUFA ↓ -5.53 
357.28 1.69 - C24:5 PUFA ↓ -3.27 
387.327 2.35 - C26:4 PUFA ↓ -3.22 
335.295 2.12 - C22:2 PUFA ↓ -3.00 
277.217 1.17 - C18:3 Linolenic PUFA ↓ -2.65 
359.295 1.92 - C24:4 PUFA ↓ -2.46 
395.389 4.93 - C26:0 SFA ↓ -2.19 
329.248 1.37 - C22:5 Docosapentaenoic acid PUFA ↓ -1.99 
367.358 4.03 - C24:0 SFA ↓ -1.93 
227.201 1.21 - C14:0 SFA ↓ -1.75 
333.28 1.85 - C22:3 PUFA ↓ -1.75 
279.233 1.36 - Linoelic PUFA ↓ -1.71 
305.248 1.47 - C20:3 Eicosatrienoic acid PUFA ↓ -1.67 
331.264 1.57 - C22:4 PUFA ↓ -1.66 
337.311 1.53 - C22:1 MUFA ↓ -1.62 
199.17 0.88 - C12 SFFA SFA ↓ -1.55 
355.264 1.47 - C24:6 PUFA ↓ -1.54 
303.233 1.32 - C20:4 Arachadonic acid PUFA ↓ -1.52 
317.248 1.45 - C21:5 PUFA ↓ -1.52 
295.227 0.61 - C18 H31 O3 HFA ↓ -1.51 
269.249 1.73 - C17:0 Heptadecanoic acid SFA ↓ -1.49 
255.233 1.55 - C16:0 Palmitic SFA ↓ -1.46 
339.326 3.2 - C22:0 SFA ↓ -1.43 
241.217 1.37 - C15:0 Pentadecanoic acid SFA ↓ -1.40 
311.295 2.5 - C20:1 MUFA ↓ -1.40 
239.201 1.15 - C15:1 MUFA ↓ -1.38 
327.233 1.21 - C22:6 Docosahexaenoic acid  PUFA ↓ -1.34 




















365.342 3.22 - C24:1 MUFA ↓ -1.34 
281.248 1.61 - C18:1 Oleic MUFA ↓ -1.28 
225.186 0.96 - C14:1 MUFA ↓ -1.23 
253.217 1.28 - C16:1 Palmitoleic acid MUFA ↓ -1.19 
267.233 1.45 - C17:1 Heptadecenoic acid MUFA ↓ -1.16 
309.28 2.01 - C20:2 PUFA ↓ -1.14 
297.28 2.22 - C19:0 SFA ↓ -1.06 
293.212 0.71 - C18 H29 O3 HFA ↓ -0.80 
295.264 1.81 - C19:1 MUFA ↑ 1.03 
325.311 2.84 - C21:0 SFA ↑ 1.03 










m/z Retention time (mins) Adduct ESI mode Lipid identity Fold change 
846.753 8.30 M+NH4 + TG(50:3) 1.92 
874.785 9.02 M+NH4 + TG(52:3) 1.57 
822.600 5.63 M-H - PE(42:4) -5.17 
764.523 4.20 M-H - PE(38:5) -3.92 
The top three identified lipids with the greatest fold change were selected for the representative scatter plots 
(Fig. 6).  
